DY-9760e, a novel calmodulin antagonist with cytoprotective action

被引:33
作者
Sugimura, M
Sato, T
Nakayama, W
Morishima, Y
Fukunaga, K
Omitsu, M
Miyamoto, E
Shirasaki, Y
机构
[1] DAIICHI PHARMACEUT CO LTD, NEW PROD RES LABS 3, EDOGAWA KU, TOKYO 134, JAPAN
[2] KUMAMOTO UNIV, SCH MED, DEPT PHARMACOL, KUMAMOTO 860, JAPAN
关键词
DY-9760e; W-7; calmodulin antagonist; cytotoxicity; neuroprotection;
D O I
10.1016/S0014-2999(97)01251-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We report the pharmacological characterization and cytoprotective effect of DY-9760e, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6- dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, a novel antagonist of calmodulin. DY-9760e inhibited calmodulin-dependent enzymes, including calmodulin-dependent phosphodiesterase and myosin light chain kinase with K-i values of 1.4, 12, 2.0, 3.8 and 133 mu M, respectively. These antagonistic effects of DY-9760e were more potent than those of W-7, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, another calmodulin antagonist. This compound showed little or no effect on calmodulin-independent enzymes, such as protein kinase A and C and calpain I and II. Analysis of the hydrophobic interaction of DY-9760e with calmodulin by using 2-p-toluidinylnaphthalene-6-sulfonate and 9-anthroylcholine revealed that, like W-7, DY-9760e bound to the hydrophobic regions of calmodulin. The [C-14]DY-9760e binding assay indicated that DY-9760e bound to calmodulin at one class of binding site. Finally, DY-9760e substantially protected N1E-115 neuroblastoma cells from cytotoxicity induced by the Ca2+ ionophore, A23187. These results indicate that DY-9760e, a novel calmodulin antagonist, possesses a cytoprotective action and suggest that calmodulin plays a critical role in mediating some of the biochemical events leading to cell death following Ca2+ overload. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 38 条
[1]  
BUISSON A, 1993, J NEUROCHEM, V61, P690
[2]   GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634
[3]  
CHOI DW, 1995, TRENDS NEUROSCI, V18, P58
[4]   DRUG-BINDING BY CALMODULIN - CRYSTAL-STRUCTURE OF A CALMODULIN TRIFLUOPERAZINE COMPLEX [J].
COOK, WJ ;
WALTER, LJ ;
WALTER, MR .
BIOCHEMISTRY, 1994, 33 (51) :15259-15265
[5]   IMMUNOSUPPRESSANT FK506 ENHANCES PHOSPHORYLATION OF NITRIC-OXIDE SYNTHASE AND PROTECTS AGAINST GLUTAMATE NEUROTOXICITY [J].
DAWSON, TM ;
STEINER, JP ;
DAWSON, VL ;
DINERMAN, JL ;
UHL, GR ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :9808-9812
[6]  
DAWSON VL, 1993, J NEUROSCI, V13, P2651
[7]   INTERACTION OF CALCIUM-ANTAGONISTS WITH CYCLIC-AMP PHOSPHODIESTERASES AND CALMODULIN [J].
EPSTEIN, PM ;
FISS, K ;
HACHISU, R ;
ANDRENYAK, DM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 105 (03) :1142-1149
[8]   PURIFICATION AND CHARACTERIZATION OF A CA-2+-DEPENDENT AND CALMODULIN-DEPENDENT PROTEIN-KINASE FROM RAT-BRAIN [J].
FUKUNAGA, K ;
YAMAMOTO, H ;
MATSUI, K ;
HIGASHI, K ;
MIYAMOTO, E .
JOURNAL OF NEUROCHEMISTRY, 1982, 39 (06) :1607-1617
[9]  
FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830
[10]  
HAJIMOHAMMADREZA I, 1995, J NEUROSCI, V15, P4093